Annual Drug Patent Expiration for DOPTELET
Doptelet is a drug marketed by Akarx Inc and included in one NDA. It is available from a single supplier. There are three patents protecting this drug.
This drug has eighteen patent family members in fourteen countries.
The generic material in DOPTELET is maleate avatrombopag. One registered supplier for this compound. Additional details are available on Avatrombopag’s maleat profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
Copyright © DrugPatentWatch. Originally published on new patent expiry for the drug DOPTELET Akarx Inc